At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZLAB Zai Lab Ltd
Trading 09-08 15:53:13 EDT
25.38
-0.85
-3.24%
High26.50Low25.38Vol612.18K
Open25.74D1 Closing26.23Amplitude4.27%
Mkt Cap2.85BTradable Cap2.46BTotal Shares112.35M
T/O15.88MT/O Rate0.63%Tradable Shares97.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)
TIPRANKS  ·  09-02
J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)
Zai Lab Surges on Global Phase III Trial Launch for Frontline Small Cell Lung Cancer
Deep News  ·  09-02
Zai Lab Surges on Global Phase III Trial Launch for Frontline Small Cell Lung Cancer
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
MT Newswires Live  ·  08-31
Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading
Is Positive ALKIVIA Myositis Data for VYVGART Hytrulo Altering The Investment Case For Zai Lab (ZLAB)?
Simply Wall St.  ·  08-31
Is Positive ALKIVIA Myositis Data for VYVGART Hytrulo Altering The Investment Case For Zai Lab (ZLAB)?
Guotai Haitong Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
TIPRANKS  ·  08-26
Guotai Haitong Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
MT Newswires Live  ·  08-25
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
MT Newswires Live  ·  08-19
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Wednesday Trading
HK Stock Alert | Zai Lab Surges Nearly 7% in Morning Trade as argenx's FcRn-Targeted Drug Succeeds in Phase 3 Trial; Zai Holds Greater China Rights
Stock News  ·  08-19
HK Stock Alert | Zai Lab Surges Nearly 7% in Morning Trade as argenx's FcRn-Targeted Drug Succeeds in Phase 3 Trial; Zai Holds Greater China Rights
Asian Equities Traded in the US as American Depositary Receipts Marginally Higher in Thursday Trading
MT Newswires Live  ·  08-13
Asian Equities Traded in the US as American Depositary Receipts Marginally Higher in Thursday Trading
Zai Lab shares surge over 5% at midday as proprietary assets enter clinical value validation phase
Deep News  ·  08-12
Zai Lab shares surge over 5% at midday as proprietary assets enter clinical value validation phase
Hong Kong Stock Market Opening: Hang Seng Index Opens 0.6% Lower, Gold Stocks Rise, ZAI LAB Surges Over 8%
Stock News  ·  08-12
Hong Kong Stock Market Opening: Hang Seng Index Opens 0.6% Lower, Gold Stocks Rise, ZAI LAB Surges Over 8%
What Is Drawing Fresh Attention To Zai Lab (ZLAB)?
Simply Wall St.  ·  08-12
What Is Drawing Fresh Attention To Zai Lab (ZLAB)?
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
MT Newswires Live  ·  08-11
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
Zai Lab Allocates Stock Options and Restricted Share Units via Incentive Plan
Stock News  ·  08-11
Zai Lab Allocates Stock Options and Restricted Share Units via Incentive Plan
Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge
Stock News  ·  08-11
Midday Hong Kong Market Wrap: Benchmark Index Dips 0.63% as CRO Concept Shares Continue to Surge
Hong Kong Stock Movers: Zai Lab Surges Over 7% on Q2 Revenue Growth and Analyst Optimism
Stock News  ·  08-11
Hong Kong Stock Movers: Zai Lab Surges Over 7% on Q2 Revenue Growth and Analyst Optimism
Hong Kong Shares Open Higher as Gold Stocks Rally, AI Application Stocks Gain Momentum
Deep News  ·  08-11
Hong Kong Shares Open Higher as Gold Stocks Rally, AI Application Stocks Gain Momentum
Zai Lab Ltd : Jefferies Cuts Target Price to $36 from $52
THOMSON REUTERS  ·  08-10
Zai Lab Ltd : Jefferies Cuts Target Price to $36 from $52
CICC Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)
TIPRANKS  ·  08-09
CICC Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)
UBS Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)
TIPRANKS  ·  08-08
UBS Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)

Introduction

Company Name.
Zai Lab Ltd
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Issue price:
--